Stephen R Pennington
Overview
Explore the profile of Stephen R Pennington including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
87
Citations
989
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Elliott A, Gill T, Kim J, Shutova M, FitzGerald O, Pennington S, et al.
J Rheumatol
. 2024 Jul;
51(Suppl 2):96-100.
PMID: 39009398
Research progress from the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) pilot award program was presented and discussed at the GRAPPA 2023 annual meeting. Topics included...
2.
Chandran V, Gladman D, Mease P, Eder L, Pennington S, FitzGerald O, et al.
J Rheumatol
. 2024 Jul;
51(Suppl 2):19-21.
PMID: 39009385
The Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) Collaborative Research Network (CRN)/research committee met during the GRAPPA 2023 annual meeting. Updates were provided on GRAPPA research...
3.
Ayan G, Aydin S, Coates L, Eder L, Gladman D, Helliwell P, et al.
J Rheumatol
. 2024 Jul;
51(Suppl 2):65-69.
PMID: 39009384
At the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) 2023 annual meeting, members were updated on a number of ongoing activities during the key project update...
4.
FitzGerald O, Behrens F, Barton A, Bertheussen H, Boutouyrie-Dumont B, Coates L, et al.
Ther Adv Musculoskelet Dis
. 2023 Sep;
15:1759720X231192315.
PMID: 37694182
Achieving a good outcome for a person with Psoriatic Arthritis (PsA) is made difficult by late diagnosis, heterogenous clinical disease expression and in many cases, failure to adequately suppress inflammatory...
5.
Ng B, Jadon D, Behrens F, de Wit M, FitzGerald O, Gladman D, et al.
J Rheumatol
. 2023 Aug;
50(Suppl 2):61-65.
PMID: 37527862
At the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) 2022 annual meeting, the Collaborative Research Network (CRN) met to present updates on several projects. These included...
6.
Ng B, Jadon D, Adebajo A, Ayan G, Callis Duffin K, Chandran V, et al.
J Rheumatol
. 2023 Aug;
50(Suppl 2):71-77.
PMID: 37527861
The Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) leadership congregated for a strategic planning meeting before the 2022 GRAPPA annual meeting in New York, USA. Meeting...
7.
Siebert S, Pennington S, Raychaudhuri S, Chaudhari A, Jin J, Liao W, et al.
J Rheumatol
. 2023 Aug;
50(Suppl 2):66-70.
PMID: 37527860
Recent basic science advances in psoriatic disease (PsD) were presented and discussed at the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) 2022 annual meeting. Topics included...
8.
Gurke R, Bendes A, Bowes J, Koehm M, Twyman R, Barton A, et al.
Biomedicines
. 2022 Oct;
10(10).
PMID: 36289648
The definitive diagnosis and early treatment of many immune-mediated inflammatory diseases (IMIDs) is hindered by variable and overlapping clinical manifestations. Psoriatic arthritis (PsA), which develops in ~30% of people with...
9.
Holm Nielsen S, Magee C, Groen S, Sinkeviciute D, Bay-Jensen A, Karsdal M, et al.
Clin Exp Rheumatol
. 2022 Aug;
41(3):574-580.
PMID: 35916294
Objectives: Around 30% of patients diagnosed with cutaneous psoriasis (PsC) will go on to develop psoriatic arthritis (PsA) which includes inflammation of the joints. Collagens are core proteins in all...
10.
Waddington J, Coleman O, Mease P, Chandran V, OSullivan D, FitzGerald O, et al.
J Rheumatol
. 2022 Apr;
49(6 Suppl 1):13-15.
PMID: 35365582
The Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) has identified several priority areas for biomarker development, including biomarkers to predict at baseline which patients may progress...